Barlow Wealth Partners’s AbbVie ABBV Stock Holding History

Barlow Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	4,334 +692	+19%	+$149K	0.12%	57
2026 Q1	$759K	Hold	3,642	–	–	0.08%	67
2025 Q4	$802K	Buy	3,642 +67	+2%	+$15.3K	0.09%	67
2025 Q3	$818K	Sell	3,575 -24	-0.7%	-$4.89K	0.09%	64
2025 Q2	$687K	Buy	3,599 +100	+3%	+$18.6K	0.08%	68
2025 Q1	$651K	Buy	3,499 +100	+3%	+$19.4K	0.09%	68
2024 Q4	$582K	Sell	3,399 -826	-20%	-$152K	0.07%	76
2024 Q3	$818K	Hold	4,225	–	–	0.11%	70
2024 Q2	$744K	Hold	4,225	–	–	0.1%	73
2024 Q1	$686K	Sell	4,225 -4	-0.1%	-$689	0.09%	76
2023 Q4	$655K	Buy	+4,229	New	+$617K	0.09%	77

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Barlow Wealth Partners's ABBV Position: Q2 2026 in Review

Barlow Wealth Partners increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $149K and bringing the position to 4,334 shares worth $1.1M. The position accounts for 0.12% of the portfolio, ranked #57.

Barlow Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Barlow Wealth Partners held 4,334 shares of AbbVie worth $1.1M as of Q2 2026.
Barlow Wealth Partners bought 692 AbbVie shares in Q2 2026, an estimated $149K.
AbbVie made up 0.12% of Barlow Wealth Partners's portfolio in Q2 2026, its #57 holding.
Barlow Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Barlow Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.